Health Apps (DiGAs) and Care Apps (DiPAs) on prescription bring enormous opportunities for patients and our entire healthcare system.

With DiGAs and DiPAs established medical device manufacturers and pharmaceutical companies can get closer to patients and providers, implement digital, data-driven business models, create a strong competitive advantage and create new revenue streams. 

Zühlke is your strategic partner for the development of DiGAs and DiPAs - from the initial idea to approval and operation. Either by co-development with startups or by creating your own digital solutions from scratch - with us you minimize your risks and optimize time-to-market. Like this, you can expand your existing portfolio quickly and securely by digital, patient-centric solutions and establish holistic therapy solutions.

' Team Zühlke have worked with us as a core part of our team to deliver the NHS Covid-19 app in a matter of months. They have brought to life a product that provides a daily benefit to the user as well as contact tracing. '
Simon Thompson
Managing Director of the NHS Covid-19 app

DiGAs and DiPAs are considered as one of the biggest breakthroughs in the digitalization of the German healthcare system. But for a lot of companies, some quite important questions remain unanswered:

  • How can you benefit from this trend as an established Medtech or Pharma company?

  • What is the best approach when developing new digital offerings?

  • What (regulatory) obligations and risks need to be considered?

  • What are the most promising business cases?

  • How can you ensure a successful collaboration with innovative ‘Tech’ partners?

To answer questions like these, it is helpful to have an experienced partner who approaches digital health innovation holistically.

Develop DiGAs and DiPAs with Zühlke.

You are looking for a trusted partner to develop innovative digital health solutions or to mitigate the risk of ongoing projects?

With Zühlke at your side, you can: 

  • Complement your existing product portfolio quickly and with minimal risk by digital solutions (DiGAs, DiPAs), which are internationally compliant (incl. approval according to MDR and FDA). 

  • Make a strategic decision to realize your own ideas, to enter partnerships or to buy solutions or providers. 

  • Extend software solutions and digital health platforms with self-developed devices - all from a single trusted partner (e.g. drug delivery systems, diagnostic devices, wearables, ...) 

We enable you to become successful with digital health solutions quickly and with minimal risk. 

Stefan Weiß
Contact person for Germany

Stefan Weiß

Lead Business Consultant

Dr. Stefan Weiss is Lead Business Innovation Consultant at the Zühlke Group and has a broad background in Neuroscience combined with a profound expertise in economics and innovation management. Before joining Zühlke, Stefan shaped the future of Healthcare and Life Sciences at the Innovation Center of Merck KGaA. He is passionate about the digitalization of the Pharma- and MedTech Industry with innovative solutions and business models by applying his scientific and economic expertise. At Zühlke, he extends technical excellence with domain-specific insights and thereby strengthens the partnerships with Pharma- and MedTech customers

Contact person for Switzerland

Blaise Jacholkowski

Principal Business Consultant

Blaise holds a Master in Microtechnology Engineering with Biomedical specialization from the EPFL as well as an Executive MBA in General Management and Finance. He joined Zühlke at the end of 2020 as Principal Business Consultant and combines 15+ years of experience in Life Sciences (Pharmaceuticals, Medtech & Healthtech) in consulting, professional services and as an entrepreneur. He tackled multiple projects in the context of digital, cultural & workforce transformation, and took part in various startup acceleration programs as a jury member in the selection committee or as a mentor. 

Nicolas Lai
Contact person for Singapore

Nicolas Lai

Health & Medtech Market Lead

Nicolas oversees the Healthcare and MedTech vertical at Zuhlke Singapore. As part of the Business Development team, he works on digital innovation initiatives together with both global and local customers. Nicolas finds joy in helping clients connect the dots, from conceptualisation to creation of exciting products.

Albert Frömel Zühlke
Contact person for Austria

Albert Frömel

Industry Lead Health & Life Sciences

Albert Frömel is responsible for the Healthcare & Life Sciences sector in Austria He draws on years of experience with leading national and international health institutions. In doing so, he actively helped shape the solution to the most important digital challenges. His focus is on digital transformation, new intelligence systems and data-driven ecosystems. Together with his team, he empowers his clients to improve patient health outcomes, modernize work environments and ensure future-proof business models. Albert Frömel completes his technical education with a degree from the Vienna University of Economics and Business Administration and regularly gives lectures at conferences.

Richard Meirion-Williams
Contact person for United Kingdom

Richard Meirion-Williams

Managing Director Markets

Richard Meirion-Williams is the Managing Director Markets in the UK. Richard sits on the Executive Board in the UK.

Julie Pourtois Zühlke
Contact person for Hong Kong

Julie Pourtois

Director Business Development

Julie Pourtois joined Zuhlke in 2020, heading the Business Development team in Hong Kong. Bringing with her over 15 years of experience in the tech industry, Julie oversees Zuhlke’s market positioning and customer portfolio across regional markets and industries in Asia. Julie strives to positively impact and uplift organisations, teams, and the larger communities she engages actively with.